The EACPR EXPERT flowchart programme : a tool to prescribe exercise training in the setting of cardiac rehabilitation Dominique Hansen, PhD, FESC Hasselt.

Slides:



Advertisements
Similar presentations
Task Force on Diabetes and CVD (ESC and EASD) European Heart Journal 2007;28:
Advertisements

Monica Colvin-Adams, MD Assistant Professor of Medicine Advanced Heart Failure and Transplantation University of Minnesota Compassionate Allowances Outreach.
To reduce the burden of cardiovascular disease in Europe.
The concept of Diabetes & CV risk: A lifetime risk challenge Diabetes & CV Risk: Routine practice versus guidelines Eberhard Standl, MD Professor of Medicine.
Promoting Excellence in Cardiovascular Disease Prevention and Rehabilitation The BACPR Standards and Core Components for Cardiovascular Prevention and.
The Benefits of Cardiac Rehabilitation By: Jenna Kong  An overview for people that are interested in participating in a program.
Orlando, Florida – October 7, 2011 Cardiac Rehab: Improving Outcomes One Step at a Time Martha Gulati MD, MS, FACC, FAHA Associate Professor of Medicine.
Appendix: Clinical Guidelines VBWG. I Intervention is useful and effective III Intervention is not useful or effective and may be harmful A Data derived.
Unstable Angina /Non-ST Elevation Myocardial Infarction Critical Pathway Toolkit Adapted from Dr Chris Cannon STRIVE Scientific Committee – 2008 Based.
Arthur Stillman, M.D., Ph.D., PI Pamela Woodard, M.D., Study Co-chair Randomized Evaluation of Patients with Stable Angina Comparing Utilization of Diagnostic.
20 Cardiovascular Disease and Physical Activity chapter.
December Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation?
E XERCISE P RESCRIPTION I N P ATIENTS W ITH C ARDIOVASCULAR D ISEASE L EANDRO C. B ONGOSIA, MD, FPCP, FPCC, FACC.
European guidelines on the management of stable coronary artery disease Key points & new position for Ivabradine and Trimetazidine ESC 2013 Montalescot.
Clinical implications. Burden of coronary disease 56 millions deaths worldwide in millions deaths worldwide in % due to CV disease (~ 16.
Multiple risk factors raise ischaemic stroke risk comparable to AF in the elderly: A large Chinese insurance analysis from 425,600 Chinese individuals.
BARI 2D Trial BARI 2D Trial Presented at the American Diabetes Association (ADA) Annual Scientific Sessions 2009 in New Orleans The Bypass Angioplasty.
Secondary Prevention & Cardiac Rehabilitation Malcolm Walker Consultant Cardiologist UCLH & the Heart Hospital, London.
The only prescription with unlimited refills. Regular exercise (150 minutes per week) lowers risk of developing heart disease, high blood pressure,
Copyright © 2011 American College of Sports Medicine Clinical Exercise Physiology Chapter 4.
Aspirin Resistance: Significance, Detection and Clinical Management of This Real Phenomenon Webcast May 10 th, 2004 Sponsored by.
Cardiac Rehabilitation 2011 Update for Primary Care Providers Douglass A Morrison, MD, PhD Cardiac Rehabilitation, Medical Director Yakima Regional and.
Dr C Raghu Interventional Cardiologist
19 Prescription of Exercise for Health and Fitness chapter.
Contemporary Management of Myocardial Ischemia
Copyright © F.A. Davis Company Part II: Applied Science of Exercise and Techniques Chapter 7 Principles of Aerobic Exercise.
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: AACVPR/ACC/AHA 2007 Performance Measures on Cardiac.
References 1.Buse JB, Ginsberg HN, Bakris GL, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Viagra (sildenafil citrate): Extensive Clinical and Post-Marketing Experience Michael Sweeney, MD Senior Medical Director Pfizer Inc.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Cardiovascular Surgery J Am Coll Cardiol.
The EAPC Exercise Prescription in Everyday Practice & Rehabilitation Training (EXPERT) tool – a digital decision support system for optimize exercise prescription.
Antonio Coca, MD, PhD, FRCP, FESC
Dominique Hansen, PhD, FESC
HESS 509 Atrial Fibrillation CHAPTER ELEVEN
The EXPERT tool: focus on prevention
Cardiac Rehabilitation Part I
Conditions & Treatments Conditions Treatments Our experts cardiologist diagnose and treat patients with coronary artery disease, heart failure, valve.
Reducing Adverse Outcomes after ACS in Patients with Diabetes Goals
Contemporary health challenges. How can physiotherapy have an impact
Endurance-type exercise combined with acipimox administration provides superior benefits for glycemic control compared with endurance-type exercise alone.
Exercise therapy in type 2 diabetes: state of the art
Prevalence and control of cardiovascular risk factors using a German sample – Findings from the STAAB Cohort Study Theresa Tiffe1,3, Götz Gelbrich1,2,
End point Patients >75 y with renal insufficiency
Individualized physical training in CV prevention and rehabilitation
RAAS Blockade: Focus on ACEI
Dominique Hansen, PhD, FESC
Jeff Macemon Waikato Cardiothoracic Unit
Exercise prescription in cardiovascular disease: guidelines vs
Chapter 1 Benefits and Risks Associated with Physical Activity
Section V: Erectile dysfunction: The patients you see
Insights from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
Chapter 2 Preparticipation Health Screening
No conflict of interest
Prescription of strength training for cardiac rehabilitation
Optimizing exercise prescription: EXPERT tool
Early strength training in cardiac surgery: how and what evidence?
Volume 145, Issue 1, Pages (January 2014)
Hospital and outpatient rehabilitation for children with heart disease
Dominique Hansen, PhD, FESC Hasselt University
Association between cardiovascular disease, cardiovascular risk factors and chronic obstructive pulmonary disease (COPD) on mortality. Association between.
Clinical case report platform
Dominique Hansen, PhD, FESC
Low/moderate intensity statins High intensity statins
Baseline predictors of acute complication of diabetes among immigrants with language barriers (N = 87,707). *Adjustment for all variables listed, as well.
Baseline predictors for risk of cardiovascular events or all-cause mortality among immigrants with language barriers (N = 87,707). *Adjustment for all.
Low/moderate intensity statins High intensity statins
Cardiovascular Epidemiology and Epidemiological Modelling
The benefits: exercise and cardiometabolic disease
Proposed future revascularisation strategy in patients with ESRD based on our current results and previous guideline recommendations. Proposed future revascularisation.
Presentation transcript:

The EACPR EXPERT flowchart programme : a tool to prescribe exercise training in the setting of cardiac rehabilitation Dominique Hansen, PhD, FESC Hasselt University, Faculty of Medicine and Life Sciences, Hasselt, Belgium Heart Centre Hasselt, Hasselt, Belgium

Introduction  Exercise-based rehabilitation is of significant importance to patients with cardiovascular disease (risk)  Better CVD risk factor control  Improved quality of life  Reductions in hospitalisation frequency  Cost saving effects

Guidelines for exercise prescription  exercise >150 min/week (spread over >2 exercise sessions/week)  low-to-moderate endurance intensity  weekly caloric expenditure of kcal/week  combination with resistance exercises Piepoli MF, Eur J Prev Cardiol 2010;17:1-17

Troubles ahead…

AMI with PCI or CABG Heart failure Cardiomyopathy Claudicating intermittens Type 2 diabetes Type 1 diabetes Hypertension Hypercholesterolemia Insulin resistance Obesity Pacemaker/ICD Cachexia Troubles ahead…

AMI with PCI or CABG Heart failure Cardiomyopathy Claudicating intermittens Type 2 diabetes Type 1 diabetes Hypertension Hypercholesterolemia Insulin resistance Obesity Pacemaker/ICD Cachexia Troubles ahead…

AMI with PCI or CABG Heart failure Cardiomyopathy Claudicating intermittens Type 2 diabetes Type 1 diabetes Hypertension Hypercholesterolemia Insulin resistance Obesity Pacemaker/ICD Cachexia Troubles ahead…

AMI with PCI or CABG Heart failure Cardiomyopathy Claudicating intermittens Type 2 diabetes Type 1 diabetes Hypertension Hypercholesterolemia Insulin resistance Obesity Pacemaker/ICD Cachexia Troubles ahead…

And what to do with prescription of certain medications?  Beta-blockers  Statins  Sulfonylurea/meglitinide  Exogenous insulin administration  … And what to do with certain anomalies during exercise testing?  Myocardial ischemia  Exercise-induced cardiac arrhythmias  … Troubles ahead…

And what to do with prescription of certain medications?  Beta-blockers  Statins  Sulfonylurea/meglitinide  Exogenous insulin administration  … And what about safety precautions during exercise for all these indications? Nobody really knows…. Troubles ahead…

for exercise prescription

Exercise intensity Interval or continuous? Session duration Exercise frequency Exercise type Minimal program duration Additional specific exercises Training modalities

Exercise = exercise? An example in type 2 diabetes Mitranun W, et al. Scand J Med Sci Sport 2014 Apr;24(2):e69-76

Exercise = exercise? An example in peripheral arterial disease

 Were the exercise modalities optimized according to type of CVD (risk factor) in previous studies?  Are then the potential maximal clinical benefits of exercise-based rehabilitation in CVD (risk) really known? Critical reflection

Efforts to optimize training prescription

EXPERT tool project  EXPERT ( EXercise Prescription in Everyday practice & Rehabilitative Training)  Launched at EuroPrevent congress 2013 in Rome  Creation of digital, interactive decision support tool for exercise prescription

 33 members (rehabilitation experts, cardiologists, rehabilitation physicians)  Dominique Hansen (coordinator, BEL), Ana Abreu (POR), Marco Ambrosetti (ITA), Olga Barna (UKR), Paul Beckers (BEL), Maurizio Bussotti (ITA), Karin Coninx (BEL), Veronique Cornelissen (BEL), Ugo Corra (ITA), Constantinos Davos (GRE), Paul Dendale (BEL), Patrick Doherty (UK), Frank Edelmann (GER), Robert Fagard (BEL), Pompilio Faggiano (ITA), Esteban Garcia- Porrero (ESP), Eva Geurts (BEL), Eugenio Greco (ITA), Evangelia Kouidi (GRE),Michel Lamotte (BEL), Daniel Neunhauserer (AUT), Joseph Niebauer (AUT), Roberto Pedretti (ITA), Massimo Piepoli (ITA), Bernhard Rauch (GER), Rona Reibis (GER), Simona Sarzi Braga (ITA), Jean-Paul Schmid (GER), Martijn Spruit (NL), Christoph Stettler (CH), Tim Takken (NL), Cajsa Tonoli (FRA), Luc Vanhees (BEL), Carlo Vigorito (ITA), Heinz Voller (GER)  out of 12 European countries EXPERT tool project

 Experts in informatics/computer science  K. Coninx and E. Geurts (BEL)  Expertise Centre for Digital Media (EDM), Hasselt University EXPERT tool project

PRIMARY INDICATIONS CVD RISK FACTORS CHRONIC DISEASES THAT MODIFY EXERCISE PRESCRIPTION EXPERT tool project

Stable CAD Congenital heart disease Cardiac transplantation Valve disease Assist devices Pacemaker/ ICD Peripheral arterial disease Cardiomyopathy Heart failure CVD RISK FACTORS CHRONIC DISEASES THAT MODIFY EXERCISE PRESCRIPTION EXPERT tool project Pulmonary hypertension

Stable CAD Congenital heart disease Cardiac transplantation Valve disease Assist devices Pacemaker/ ICD Peripheral arterial disease Cardiomyopathy Heart failure Type 2 diabetes Type 1 diabetes ObesityDyslipidemiaHypertension CHRONIC DISEASES THAT MODIFY EXERCISE PRESCRIPTION EXPERT tool project Pulmonary hypertension

Stable CAD Congenital heart disease Cardiac transplantation Valve disease Assist devices Pacemaker/ ICD Peripheral arterial disease Cardiomyopathy Heart failure Type 2 diabetes Type 1 diabetes ObesityDyslipidemiaHypertension Pulmonary hypertension Sarcopenia Chronic pulmonary disease Renal failure EXPERT tool project

Tool in digital format

 Position papers  Validation phase and first clinical study  Big European study in 2016 and beyond  Continuous update of tool  Extensions on tool Next steps in project

To all colleagues who contribute… Contact: